Cited by 198Bone health and osteoporosis researchHormonal and reproductive studiesEstrogen and related hormone effects

Gonadal steroid–dependent effects on bone turnover and bone mineral density in men

Open access
Finkelstein, Joel S., Lee, Hang, Leder, Benjamin Z., Burnett-Bowie, Sherri-Ann M., Goldstein, David W., Hahn, Christopher W., Hirsch, Sarah C., Linker, Alex +6 more·2016·Journal of Clinical Investigation

Abstract

BACKGROUND: Severe gonadal steroid deficiency induces bone loss in adult men; however, the specific roles of androgen and estrogen deficiency in hypogonadal bone loss are unclear. Additionally, the threshold levels of testosterone and estradiol that initiate bone loss are uncertain. METHODS: One hundred ninety-eight healthy men, ages 20-50, received goserelin acetate, which suppresses endogenous gonadal steroid production, and were randomized to treatment with 0, 1.25, 2.5, 5, or 10 grams of testosterone gel daily for 16 weeks. An additional cohort of 202 men was randomized to receive these treatments plus anastrozole, which suppresses conversion of androgens to estrogens. Thirty-seven men served as controls and received placebos for goserelin and testosterone. Changes in bone turnover markers, bone mineral density (BMD) by dual-energy x-ray absorptiometry (DXA), and BMD by quantitative computed tomography (QCT) were assessed in all men. Bone microarchitecture was assessed in 100 men. RESULTS: As testosterone dosage decreased, the percent change in C-telopeptide increased. These increases were considerably greater when aromatization of testosterone to estradiol was also suppressed, suggesting effects of both testosterone and estradiol deficiency. Decreases in DXA BMD were observed when aromatization was suppressed but were modest in most groups. QCT spine BMD fell substantially in all testosterone-dose groups in which aromatization was also suppressed, and this decline was independent of testosterone dose. Estradiol deficiency disrupted cortical microarchitecture at peripheral sites. Estradiol levels above 10 pg/ml and testosterone levels above 200 ng/dl were generally sufficient to prevent increases in bone resorption and decreases in BMD in men. CONCLUSIONS: Estrogens primarily regulate bone homeostasis in adult men, and testosterone and estradiol levels must decline substantially to impact the skeleton. TRIAL REGISTRATION: ClinicalTrials.gov, NCT00114114. FUNDING: AbbVie Inc., AstraZeneca Pharmaceuticals LP, NIH.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci84137

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Oestradiol may be important for sexual function, prevention of abdominal adiposity, and insulin sensitivity.

    “In addition to bone health, 119 oestradiol may be important for of sexual function, prevention of abdominal adiposity 68 and insulin sensitivity.69,120”

    From Hypogonadism and male obesity: Focus on unresolved questions (2018) · cites this paper as [119]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Finkelstein, J. S., Lee, H., Leder, B. Z., Burnett-Bowie, S.-A. M., Goldstein, D. W., Hahn, C. W., Hirsch, S. C., Linker, A., Perros, N., Servais, A. B., Taylor, A. P., Webb, M. L., Youngner, J. M., & Yu, E. W.
Affiliations
Massachusetts General Hospital (US)
Venue
Journal of Clinical Investigation
Published
2016-02-22
Volume
126
Issue
3
Pages
1114-1125
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W2276919011
Cited by
198
References
47
Citations by year
2026: 17 · 2025: 13 · 2024: 16 · 2023: 20 · 2022: 24 · 2021: 14 · 2020: 24 · 2019: 25 · 2018: 20 · 2017: 19 · 2016: 5
FWCI
28.00
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Massachusetts General Hospital
  • National Institutes of Health
  • National Institute on Aging (R01AG030545)
  • National Center for Research Resources (UL1RR025758, M01RR001066, P41RR002305)
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
Keywords
hypogonadism, testosterone, estradiol, bone mineral density, bone turnover, bone resorption, androgen deficiency, estrogen deficiency, aromatase inhibition, anastrozole, goserelin, bone microarchitecture, men
MeSH terms
Adult, Estradiol, Eunuchism, Humans, Male, Middle Aged, Osteoporosis, Testosterone, Bone Density, Bone Remodeling, Treatment Outcome, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review